Efficacy and safety of diphereline 11.25 mg, microrelin 11.25 mg, and microrelin 3.75 mg in premenopausal patients with breast cancer: a non-inferiority randomized clinical trial

BACKGROUND: Diphereline is a Gonadotropin-Releasing Hormone agonist commonly used in patients with breast cancer. This study aimed to compare the efficacy and safety of one-month and three-month Microrelin injections produced by Homa Pharmed Company with three-month Diphereline injections manufactur...

Descripción completa

Detalles Bibliográficos
Autores principales: Najafi, Safa, Ansari, Maryam, Omidi, Zahra, Olfatbakhsh, Asiie, Moghadam, Shiva, Hashemi, Esmat-o-Sadat, Najafi, Niki, Haghighat, Shahpar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638790/
https://www.ncbi.nlm.nih.gov/pubmed/37950162
http://dx.doi.org/10.1186/s12885-023-11614-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638790/
https://www.ncbi.nlm.nih.gov/pubmed/37950162
http://dx.doi.org/10.1186/s12885-023-11614-7

Ejemplares similares